Acknowledgement
We are grateful to the parents who provided consent to use the data of their children.
References
- Iacobas I, Phung TL, Adams DM, Trenor CC 3rd, Blei F, Fishman DS, et al. Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring. J Pediatr 2018;203:294-300.e2. https://doi.org/10.1016/j.jpeds.2018.08.012
- Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al.; ISSVA Board and Scientific Committee. Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 2015;136:e203-14. https://doi.org/10.1542/peds.2014-3673
- Gnarra M, Behr G, Kitajewski A, Wu JK, Anupindi SA, Shawber CJ, et al. History of the infantile hepatic hemangioma: from imaging to generating a differential diagnosis. World J Clin Pediatr 2016;5:273-80. https://doi.org/10.5409/wjcp.v5.i3.273
- Zavras N, Dimopoulou A, Machairas N, Paspala A, Vaos G. Infantile hepatic hemangioma: current state of the art, controversies, and perspectives. Eur J Pediatr 2020;179:1-8. https://doi.org/10.1007/s00431-019-03504-7
- Kulungowski AM, Alomari AI, Chawla A, Christison-Lagay ER, Fishman SJ. Lessons from a liver hemangioma registry: subtype classification. J Pediatr Surg 2012;47:165-70. https://doi.org/10.1016/j.jpedsurg.2011.10.037
- Christison-Lagay ER, Burrows PE, Alomari A, Dubois J, Kozakewich HP, Lane TS, et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 2007;42:62-7; discussion 67-8. https://doi.org/10.1016/j.jpedsurg.2006.09.041
- Liang MG, Frieden IJ. Infantile and congenital hemangiomas. Semin Pediatr Surg 2014;23:162-7. https://doi.org/10.1053/j.sempedsurg.2014.06.017
- Mhanna A, Franklin WH, Mancini AJ. Hepatic infantile hemangiomas treated with oral propranolol--a case series. Pediatr Dermatol 2011;28:39-45. https://doi.org/10.1111/j.1525-1470.2010.01355.x
- Sarialioglu F, Yazici N, Erbay A, Boyvat F, Demir S, Ozcay F, et al. A new perspective for infantile hepatic hemangioma in the age of propranolol: experience at Baskent University. Exp Clin Transplant 2017;15(Suppl 2):74-8.
- Ernst L, Grabhorn E, Brinkert F, Reinshagen K, Konigs I, Trah J. Infantile hepatic hemangioma: avoiding unnecessary invasive procedures. Pediatr Gastroenterol Hepatol Nutr 2020;23:72-8. https://doi.org/10.5223/pghn.2020.23.1.72
- Florian-Tutaya LS, Cuba-Valencia L, Bustamante-Encinas SF, Vela-Alfaro FM. Successful use of propranolol in a symptomatic giant congenital hepatic hemangioma. J Neonatol 2020;34:99-102. https://doi.org/10.1177/0973217920928645
- Kawahara Y, Nijima H, Suzuki Y, Furukawa R, Morimoto A. Successful use of propranolol for congenital hepatic hemangioma with Kasabach-Merritt phenomenon. Pediatr Int 2017;59:634-6. https://doi.org/10.1111/ped.13244
- Docx MKF, Vandenberghe P, De Broek V, Govaert P. Propranolol therapy for an abdominal giant haemangioma in a neonate. J Nepal Paediatr Soc 2015;35:189-91. https://doi.org/10.3126/jnps.v35i2.13877
- Baena-Gomez MA, Priego Ruiz MP, Mateos Gonzalez E, Pena Rosa MJ, Munoz Sanchez R. [Hepatic hemangiomas: spectacular response to treatment with propranolol]. An Pediatr (Barc) 2015;83:435-7. Spanish. https://doi.org/10.1016/j.anpedi.2015.05.008
- Tsai MC, Liu HC, Yeung CY. Efficacy of infantile hepatic hemangioma with propranolol treatment: a case report. Medicine (Baltimore) 2019;98:e14078.
- Lekwuttikarn R, Josephs S, Teng JM. Successful medical management of life-threatening hepatic hemangioma in neonates. Pediatrics 2019;144:e20191339.
- Lewis D, Hachey K, Fitzgerald S, Vaidya R. Rapidly involuting congenital haemangioma of the liver. BMJ Case Rep 2018;2018:bcr2018224337.
- Koh SP, Leadbitter P, Smithers F, Tan ST. β-blocker therapy for infantile hemangioma. Expert Rev Clin Pharmacol 2020;13:899-915. https://doi.org/10.1080/17512433.2020.1788938